Telix Pharmaceuticals (TLX) Liabilities and Shareholders Equity (2023 - 2025)
Telix Pharmaceuticals (TLX) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $1.2 billion as the latest value for Q4 2025.
Telix Pharmaceuticals (TLX) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $1.2 billion as the latest value for Q4 2025.